testolactone has been researched along with medroxyprogesterone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Styne, DM; Wheeler, MD | 2 |
| Hauffa, BP; Havers, W; Stolecke, H | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Goldenberg, IS | 1 |
| Feldhammer, B; Koldovsky, U; von Matthiessen, H | 1 |
1 review(s) available for testolactone and medroxyprogesterone
| Article | Year |
|---|---|
The treatment of precocious puberty.
Topics: Androgen Antagonists; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty, Precocious; Testolactone | 1991 |
1 trial(s) available for testolactone and medroxyprogesterone
| Article | Year |
|---|---|
Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorometholone; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Testolactone | 1969 |
5 other study(ies) available for testolactone and medroxyprogesterone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Diagnosis and management of precocious puberty.
Topics: Child; Child, Preschool; Diagnosis, Differential; Female; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty; Puberty, Precocious; Testolactone | 1990 |
Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
Topics: Androgen Antagonists; Body Height; Bone Development; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follow-Up Studies; Humans; Infant; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Function Tests; Spironolactone; Testolactone | 1987 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
[3H-thymidine incorporation under endocrine influence and hormone receptor content of human mammary carcinoma (author's transl)].
Topics: Breast Neoplasms; Estradiol; Female; Humans; Medroxyprogesterone; Receptors, Estrogen; Receptors, Progesterone; Testolactone; Thymidine | 1980 |